Recent studies found that CRBP-1 was down-regulated in certain human cancer tissues, including prostate cancer [17], breast cancer [18], endometrial cancer [19] and ovarian cancer [20], and that CRBP-1 was up-regulated in lung adenocarcinoma [15] and laryngeal cancer [21]. Here, RBP1 is linked to ovarian carcinoma.